Bedrocan founder Tjalling Erkelens says the bankruptcy trustees and judge-commissioner have approved a restart under a new company, Erkelens Fytofarma. But financing remains incomplete, a purchase agreement is unsigned, and the Dutch medical cannabis supply faces a deadline.
A restart bid moves forward, but the money is missing
Bedrocan's founding family has won backing for a proposed restart of the bankrupt Dutch medical cannabis producer, but the plan is not yet finalized.
In their first public bankruptcy report, filed November 9, the court-appointed trustees said they had selected a restart bid for the Dutch operations, without naming the bidder. Dutch trade press reported the selected bid is the Erkelens family's, judged the best of several.
Founder Tjalling Erkelens told Business of Cannabis that the administrators and judge-commissioner had approved restarting the Dutch facilities through a new company. He said partial financing was secured, but additional funding was still needed.
That account goes further than the trustees' November 9 report, which said the selected bid was still awaiting approval from the supervisory judge.
The new company, Erkelens Fytofarma, needs about 3 million euros initially and is seeking an investor.
The new company would focus on exports
The proposed operation would produce EU-GMP cannabis raw material and active pharmaceutical ingredients for extracts and registered medicines, using Bedrocan's Emmeloord production site and Veendam headquarters.
Bedrolite, its CBD-dominant variety, is still being grown during the bankruptcy, and the family says it aims to keep producing it in the Netherlands. Supplying the Dutch market is not currently possible because the government's service agreement ended January 1, 2026.
However, the trustees' November 9 bankruptcy report says a draft purchase agreement remains unsigned. The successor could employ at most 10 of Bedrocan Nederland's 69 dismissed workers. The Bedrocan trade name was also sold to Becanex, a separate Dutch cannabis company, which bought Bedrocan's Canadian shares and intellectual property for 200,000 euros.
The minister and founder dispute what caused the collapse
Health Minister Sophie Hermans told parliament on November 6 that the government refused to financially support Bedrocan, pay invoices before quality checks or take over remaining stock because the state already held enough.
She disputed that ending the government contract caused the bankruptcy, saying orders remained outstanding, with the final batch due in November 2026.
On November 12, Erkelens accused the minister of selectively informing parliament about the bankruptcy. The dispute is expected to feature in a parliamentary debate scheduled for November 26, 2026.
Patients face a longer-term supply question
According to the minister, the Bureau Medicinale Cannabis expects its final pharmacy deliveries of Bedrocan, Bedica and Bediol around the middle of the third quarter of 2027, Bedrolite early in that quarter and Bedrobinol early in the second quarter — dates that partly reflect shelf-life requirements rather than the physical exhaustion of stock.
About 7,000 Dutch patients use prescribed medical cannabis. The government is also investigating whether the United Kingdom can receive Bedrolite for slightly longer. Business of Cannabis reports that around seven UK patients rely on the variety for severe epilepsy, with no surplus stock following a harvest failure of more than 50 percent.
The Bureau Medicinale Cannabis plans to publish a European tender in December 2026, select a replacement supplier in May 2027 and begin deliveries in September 2027. A planned amendment ending the state monopoly will miss its July 1, 2028 target, with no replacement date established.
For now, the proposed restart remains dependent on financing and a completed purchase agreement.
Sources
- Bedrocan trustees, First Public Bankruptcy Report, filed November 9, 2026
- Sophie Hermans, Minister of Health, Welfare and Sport, letter to the Tweede Kamer, November 6, 2026
- Business of Cannabis, “Bedrocan Restart Bid Could See Company Revived,” November 12, 2026 Link
- Cannabis Industrie (Netherlands), Bedrocan bankruptcy coverage, November 9-12, 2026 Link

Read next
Senate Spending Bill Continues State Medical Marijuana Protections, Omits House Anti-Rescheduling Riderarticles · Nov 13, 2026
Decibel Cannabis Starts Trading on the OTCQX Best Marketarticles · Nov 13, 2026
California Proposes Ending Random Marijuana Testing for Covered State Employeesarticles · Nov 13, 2026
Auxly Posts a Record Quarter in Canadaarticles · Nov 12, 2026
- Bedrocan trustees, First Public Bankruptcy Report, filed November 9, 2026.
- Sophie Hermans, Minister of Health, Welfare and Sport, letter to the Tweede Kamer, November 6, 2026.
- Business of Cannabis, "Bedrocan Restart Bid Could See Company Revived," November 12, 2026.
- Cannabis Industrie (Netherlands), Bedrocan bankruptcy coverage, November 9-12, 2026.
0 comments